New restrictions on prescribing hydroxychloroquine

26 Mar 2020

The AMA is aware of reports regarding hydroxychloroquine and its inappropriate use as a therapeutic for COVID-19, and has responded quickly to this issue by working with the Department of Health and the TGA. 

This medication is important for many patients, particularly those with auto-immune disorders, and it is essential that these patients continue to have a supply.  

As of 24 March 2020, there are new restrictions for prescribing hydroxychloroquine. Initial treatment of hydroxychloroquine must be authorised by a medical practitioner under the following specialties: 

  • Dermatology
  • Intensive care medicine
  • Paediatrics and child health 
  • Physician
  • Emergency medicine